Olympus Corp
Health Care
Current price
Target price 00%
Ranks rating
76
Position in sub-industry
261 / 663
Position in country
3579 / 4811
Net income margin, %
7.9
-12.5
EBITDA margin, %
23.7
-2.5
Debt to Equity, %
40.6
15
Intangible assets and goodwill, %
18.5
3.9
P/E
66.5
28.3
P/BV
3.3
1.7
P/S
2.8
3.7
EV/S
2.7
3.2
EV/EBITDA
16.6
-0.2
Dividend Yield, %
0.8
1.8
Payout Ratio, %
50.8
17.3
Competitors
Ranks
-
Fukuda Denshi Co Ltd
00%
-
Nakanishi Inc
00%
-
Terumo Corp
00%
-
JEOL Ltd
00%
-
Paramount Bed Holdings Co Ltd
00%
-
Sysmex Corp
00%
-
Olympus Corp
00%
-
Abbott Laboratories
00%
-
Nihon Kohden Corp
00%
-
PHC Holdings Corp
00%
Ready-made portfolio of the best Russian stocks
- Created by artificial intelligence
- Verified by analysts
- Available even to beginners
Company information
Country
Japan
Sector
Health Care
Industry group
Health Care Equipment & Services
Industry
Health Care Equipment & Supplies
Sub-sector
Health Care
Capitalization (millions of $)
17120.8
Ticker
OCPNY.PK
ISIN
US68163W2089
IPO date
1949-05-16
Availability on Russian exchanges
No
Reporting for
2024-02-14
Date fact. publication of reports
2023-12-31
Company Description
Olympus Corp is a Japan-based company mainly engaged in the manufacture and sale of endoscopes, therapeutic equipment, science, video and other products. The Company operates in five business segments. The Endoscopy segment provides gastrointestinal endoscopy, surgical endoscopy, endoscopy systems and repair services. The Therapeutic Equipment segment provides endoscopic treatment tools, energy devices, urology, gynecology and otolaryngology products. The Scientific segment provides biological microscope, industrial microscope, industrial endoscope and non-destructive inspection equipment. The Imaging segment provides digital cameras and recording machines. The Others segment is engaged in the manufacture and sale of biomaterials. The Company is also engaged in the financial investment business.
A step towards better analytics
- find the best promotions through the Screener
- keep an eye on stock valuation
- download detailed reports
and much more after free registration
RegistrationMore convenient from your phone? Download: